Navigation Links
NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
Date:1/3/2008

SOPHIA ANTIPOLIS, France, Jan. 3 /PRNewswire/ -- NicOx S.A. (Euronext Paris: COX) today announced that Pfizer Inc (NYSE: PFE) has initiated a dose-ranging phase 2 clinical study for PF-03187207 in Japan. PF-03187207 is a new experimental medicine for the treatment of glaucoma, which is currently in an ongoing phase 2 proof-of-concept study in the United States (see press releases of March 28 and 29, 2007). Glaucoma and ocular hypertension are a group of severe eye diseases that can lead to blindness and this new Japanese study will compare the safety and efficacy of PF-03187207 to Xalatan(R) (latanoprost) in Japanese patients with these conditions. Xalatan(R) is a proprietary Pfizer product and the leader in worldwide glaucoma sales, with approximately $1.5 billion of franchise sales in 2006.

PF-03187207 is the lead development compound generated under the August 2004 collaboration agreement between Pfizer and NicOx, which focuses on the research and development of nitric oxide-donating prostaglandin F2-alpha analogs for the treatment of glaucoma (see NOTE).

Maarten Beekman, Vice President of Clinical Development at NicOx, said: "We believe the initiation of this separate Japanese study for PF-03187207 highlights Pfizer's determination to rapidly advance this clinical program towards coordinated regulatory filing in the world's major pharmaceutical markets. Preclinical results have suggested that NicOx' technology has the potential to deliver improved treatments for glaucoma and we look forward to the results of the ongoing proof-of-concept phase 2 study for PF-03187207 in the United States."

Design and rationale for the study

The first clinical study for PF-03187207, initiated in March 2007 in the United States
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
2. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
3. NicOx Naproxcinod ABPM Data Presented at American Heart Association
4. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
5. NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
6. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... April 20, 2015  Teradata (NYSE: TDC ... marketing applications company, today announced the ... Analytics Framework for Life Sciences helps organizations integrate ... and Early Discovery (RED), clinical analysis, Real-World Evidence ... relevant sources, companies can benefit by bringing safer, ...
(Date:4/20/2015)... WASHINGTON , April 20, 2015 Pharmaceutical ... an estimated $51.2 billion last year in the research ... The figure represents the majority of all biopharmaceutical R&D ... the United States . The new R&D ... member companies, are highlighted in the newly released ...
(Date:4/20/2015)... Ill. , April 20, 2015  U.S. pharmacy cost ... expected to drift into the low double-digits by 2016, according ... talent, retirement and health solutions business of Aon plc ... design changes are projected to be 9.5 percent in 2015 ... Aon Hewitt predicts a similar rate of increase ...
Breaking Medicine Technology:Teradata Delivers Big Analytics Innovation for Life Sciences 2Teradata Delivers Big Analytics Innovation for Life Sciences 3Teradata Delivers Big Analytics Innovation for Life Sciences 4PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 2PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4
... Dec. 23 BioTrends Research Group, Inc. published ... in the United States," based on ... clinical practice. The report evaluates patient types, ... Hematologists, Oncologists, Nephrologists, Gastroenterologists, OB-GYNs, Rheumatologists, Cardiologists and ...
... , , , PARIS, December ... discovery and development of novel antibiotics,designed to overcome the ... its shareholders have signed a definitive,agreement whereby Novexel shall ... up to $505 million, including contingent payments and the,net ...
Cached Medicine Technology:BioTrends Publishes New Report Exploring Treatment Patterns for Anemia Across a Variety of Physician Specialties 2Novexel to be Acquired by AstraZeneca 2Novexel to be Acquired by AstraZeneca 3Novexel to be Acquired by AstraZeneca 4
(Date:4/21/2015)... (PRWEB) April 21, 2015 The Northeast ... the beautiful Governor’s Academy prep school in Byfield, MA. ... 10-12, 2015, for boys entering grades 6-12. , The ... supplement the players’ fall coaching. , Offensive ... Not only are these the most unsung positions on ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 Dr. Zain ... just released an interesting infographic that takes a close look ... , The new infographic, which appears on both Dr. Kadri’s ... Rise of Plastic Surgery in the Age of the Selfie.” ... in Beverly Hills to a variety of A-list patients, ...
(Date:4/21/2015)... Freeslate, Inc ., the leading provider ... that the Centre for Catalysis Research and Innovation ... a Freeslate Core Module 3 (CM3) Reaction Screening ... to accelerate current research programs. The systems will be ... be available to academic users and industrial collaborators/ partners ...
(Date:4/21/2015)... RI (PRWEB) April 21, 2015 Spring ... trips, with many people visiting family for the holidays ... household pets while planning to travel can be a ... choosing to travel with pets is becoming a more ... tips for making a stay at pet-friendly accommodations a ...
(Date:4/21/2015)... This program provides physical therapists, ... occupational therapist assistants, teachers, and other school based ... children across the autism spectrum succeed in the ... Inc. , Used throughout the United ... yoga curriculum addresses learning and behavior issues across ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:Beverly Hills Plastic Surgery Expert Dr. Zain Kadri Releases Thought-Provoking New Infographic 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 2Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 3Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 4Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2
... delusional was removed and the name was shortened as Calgaria. ... the content and presentation// continue to insult those afflicted by ... to be light-hearted about this, but those of us living ... it quite insulting,” said Roy Muir, who suffers from depression ...
... study finds that stents do not prevent heart attacks ... chest pains and to prevent heart attacks//. Stents are ... them open. ,This landmark study funded by ... do improve blood flow but are no more effective ...
... to AAWL in adults between the ages of 18 ... ,Arthritis, a leading cause of disability among ... (AAWL) can have substantial social and economic impacts including ... ,This study was published in the April ...
... Kickboxing can cause damage to the pituitary gland, a pea-sized ... the bridge of the nose//, scientists say. ,The ... things, the body's regulation of metabolism coping with daily stress, ... team at Erciyes University Medical School in Turkey measured the ...
... that people whose diets contain dramatically more of one ... at greater risk// for both clinical depression and certain ... week in the journal Psychosomatic Medicine, suggests that we ... omega-3 fatty acids. The current typical American diet contains ...
... pain, an important component of diagnosis, are now revealed to ... previously thought.// ,Spatial aspects of pain are a ... on the study and a neuroscientist at Wake Forest University ... and pain from a heart attack, for example. Pain from ...
Cached Medicine News:Health News:Stents Do Little to Prevent Heart Attacks 2Health News:AAWL Affects Quality of Life 2Health News:AAWL Affects Quality of Life 3Health News:Omega-3 Fatty Acids Affect Risk of Depression, Inflammation 2Health News:Omega-3 Fatty Acids Affect Risk of Depression, Inflammation 3Health News:Multiple Regions of the Brain Locate Pain 2
... One of the smallest handheld oximeters ... spot-check solution for hospital, home care, transport, ... standard features., ,PIr (relative perfusion index ... for a dynamic numeric reflection of perfusion ...
... power of clinical information. , ,S/5 ... clinical connectivity solutions that help you and ... patient care. You will have access to ... share it with your care team and ...
... value for size., ,The Datex-Ohmeda S/5 Light ... use in anesthesia and critical care areas, in ... inter-hospital transport. As part of the Datex-Ohmeda S/5 ... intuitive user interface and design shared by all ...
... the operating and recovery room, ,The ... combined haemodynamic and airway gas monitoring for ... care units. The Cardiocap II is available ... basic haemodynamic measurements. Two of the models ...
Medicine Products: